A Rüdeberg

1.1k total citations
18 papers, 852 citations indexed

About

A Rüdeberg is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, A Rüdeberg has authored 18 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Pediatrics, Perinatology and Child Health and 2 papers in Molecular Biology. Recurrent topics in A Rüdeberg's work include Cystic Fibrosis Research Advances (9 papers), Pneumonia and Respiratory Infections (2 papers) and Epilepsy research and treatment (2 papers). A Rüdeberg is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Pneumonia and Respiratory Infections (2 papers) and Epilepsy research and treatment (2 papers). A Rüdeberg collaborates with scholars based in Switzerland and United States. A Rüdeberg's co-authors include Richard Kraemer, E. Rossi, B. Hadorn, Sabina Liechti‐Gallati, Richard C. Hubbard, Ronald G. Crystal, P. Birrer, Noel G. McElvaney, Aloïs B. Lang and E Fürer and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Pediatrics and Developmental Medicine & Child Neurology.

In The Last Decade

A Rüdeberg

18 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rüdeberg Switzerland 10 623 155 148 113 93 18 852
Khin M. Gyi United Kingdom 12 575 0.9× 44 0.3× 86 0.6× 130 1.2× 39 0.4× 14 806
Sheila G. McKenzie Switzerland 11 890 1.4× 51 0.3× 115 0.8× 102 0.9× 29 0.3× 14 1.1k
V. Vávrová Czechia 14 542 0.9× 22 0.1× 108 0.7× 77 0.7× 23 0.2× 39 690
Thomas F. Scanlin United States 22 688 1.1× 241 1.6× 424 2.9× 67 0.6× 299 3.2× 51 1.2k
Christina Smaczny Germany 12 341 0.5× 37 0.2× 102 0.7× 101 0.9× 36 0.4× 24 506
Jonathan B. Zuckerman United States 17 552 0.9× 20 0.1× 359 2.4× 117 1.0× 31 0.3× 44 997
Elias Matouk Canada 16 637 1.0× 13 0.1× 279 1.9× 106 0.9× 41 0.4× 29 911
S. Brennan Australia 14 595 1.0× 21 0.1× 204 1.4× 112 1.0× 15 0.2× 24 820
Simon Y. Graeber Germany 22 1.2k 1.9× 18 0.1× 269 1.8× 156 1.4× 15 0.2× 49 1.5k
Tetyana Zakharkina Germany 10 216 0.3× 7 0.0× 223 1.5× 104 0.9× 51 0.5× 10 636

Countries citing papers authored by A Rüdeberg

Since Specialization
Citations

This map shows the geographic impact of A Rüdeberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rüdeberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rüdeberg more than expected).

Fields of papers citing papers by A Rüdeberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rüdeberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rüdeberg. The network helps show where A Rüdeberg may publish in the future.

Co-authorship network of co-authors of A Rüdeberg

This figure shows the co-authorship network connecting the top 25 collaborators of A Rüdeberg. A scholar is included among the top collaborators of A Rüdeberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rüdeberg. A Rüdeberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lang, Aloïs B., A Rüdeberg, Martin H. Schöni, et al.. (2004). Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection. The Pediatric Infectious Disease Journal. 23(6). 504–510. 67 indexed citations
2.
Rüdeberg, A, et al.. (2000). [Psychosocial approach to cystic fibrosis in adults].. PubMed. 17(3 Pt 2). 812–6. 2 indexed citations
3.
Rüdeberg, A, et al.. (1997). Acute metabolic alkalosis in cystic fibrosis: prospective study and review of the literature.. PubMed. 23(1). 33–7. 16 indexed citations
4.
Cryz, Stanley J., Aloïs B. Lang, A Rüdeberg, et al.. (1997). Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.. PubMed. 345–9. 39 indexed citations
5.
Lang, Aloïs B., Urs B. Schaad, A Rüdeberg, et al.. (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. The Journal of Pediatrics. 127(5). 711–717. 41 indexed citations
6.
Rüdeberg, A, Filippo Donati, & Georges L. Kaiser. (1995). Psychosocial aspects in the treatment of children with myelomeningocele: An assessment after a decade. European Journal of Pediatrics. 154(S4). S85–S89. 8 indexed citations
7.
Aebi, Christoph, et al.. (1995). The age at onset of chronicPseudomonas aeruginosa colonization in cystic fibrosis —prognostic significance. European Journal of Pediatrics. 154(S4). S69–S73. 34 indexed citations
8.
Birrer, P., Noel G. McElvaney, A Rüdeberg, et al.. (1994). Protease-Antiprotease Imbalance in the Lungs of Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 150(1). 207–213. 315 indexed citations
9.
Marchesi, Dante, A Rüdeberg, & Max Aebi. (1991). [Development in conservatively treated scoliosis in patients with myelomeningocele (patients of the years 1964-1977)].. PubMed. 57(4). 390–8. 2 indexed citations
10.
Slongo, Th, et al.. (1989). Erfahrungen mit der Frühbehandlung der Osteogenesis imperfecta (Ol). European Journal of Pediatric Surgery. 44(5). 293–296. 1 indexed citations
11.
Kaiser, Georges L. & A Rüdeberg. (1986). Comments on the Management of Newborn with Spina Bifida Cystica - Active Treatment or No Treatment. European Journal of Pediatric Surgery. 41(3). 141–143. 2 indexed citations
12.
Schäffler, L., et al.. (1982). Conventional and spectral EEG analysis in children treated with cytotoxic agents. European Journal of Cancer and Clinical Oncology. 18(9). 827–832. 2 indexed citations
13.
Kraemer, Richard, U. B. Schaad, G. Lebek, A Rüdeberg, & E. Rossi. (1982). Sputum penetration of fusidic acid in patients with cystic fibrosis. European Journal of Pediatrics. 138(2). 172–175. 9 indexed citations
14.
Zysset, Thomas, A Rüdeberg, F Vassella, A Küpfer, & J Bircher. (1981). Phenytoin Therapy for Epileptic Children: Evaluation of Salivary and Plasma Concentrations and of Methods of Assessing Compliance. Developmental Medicine & Child Neurology. 23(1). 66–75. 8 indexed citations
15.
Kraemer, Richard, et al.. (1979). Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis.. PubMed. 34(5). 417–28. 23 indexed citations
16.
Kraemer, Richard, H Tschäppeler, A Rüdeberg, Elizabeth A. Stoll, & Emanuela Rossi. (1979). [Course and quantitative evaluation of the lung involvement in cystic fibrosis].. PubMed. 109(2). 39–45. 6 indexed citations
17.
Vassella, F, et al.. (1978). [Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome].. PubMed. 108(19). 713–6. 18 indexed citations
18.
Kraemer, Richard, A Rüdeberg, B. Hadorn, & E. Rossi. (1978). RELATIVE UNDERWEIGHT IN CYSTIC FIBROSIS AND ITS PROGNOSTIC VALUE. Acta Paediatrica. 67(1). 33–37. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khin M. Gyi Breakdown of academic impact, for papers by Sheila G. McKenzie Breakdown of academic impact, for papers by V. Vávrová Breakdown of academic impact, for papers by Thomas F. Scanlin Breakdown of academic impact, for papers by Christina Smaczny Breakdown of academic impact, for papers by Jonathan B. Zuckerman Breakdown of academic impact, for papers by Elias Matouk Breakdown of academic impact, for papers by S. Brennan Breakdown of academic impact, for papers by Simon Y. Graeber Breakdown of academic impact, for papers by Tetyana Zakharkina
Rankless by CCL
2026